SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Coronavirus / COVID-19 Pandemic
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Triffin who wrote (5715)7/14/2020 10:51:09 PM
From: Investor21 Recommendation

Recommended By
Savant

  Read Replies (1) of 22882
 
Yes, I heard about that study earlier today. The irvermectin cocktail (100% recovery rate) and the HCQ cocktail (96.36% recovery rate) were both very effective treatments as compared to the control group.

Another study came out today that concluded that adding irvermectin to a HCQ/ARZ cocktail improved the treatment effectiveness.

It should be noted that both studies came out as pre-prints; they have not yet been peer reviewed.

Nevertheless, this is great news! We need cures! Especially with the reports coming out that the antibodies may not last very long, which calls into question the viability of vaccines.

Best wishes,

I2
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News